lobbying_activities: 3444234

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3444234	5e771b10-020f-45d3-8cd0-77dbd2c2d81a	Q3	THE RABEN GROUP	61458	BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND)	2025	third_quarter	CHM	Education on strengthening FDA authority and the safety of personal care products, including ingredient and supply chain transparency, restricting the use of hazardous ingredients, promoting beauty justice, and protections for professional salon workers. Implementation of the Modernization of Cosmetics Regulation Act of 2022. Proposals that address the FDA's Generally Recognized As Safe (GRAS) standard and Delaney Clause authority, and legislation to reassess and ban toxic food additives and hazardous chemicals in food contact materials. Funding for the Centers for Disease Control and Prevention National Biomonitoring Program and National Health Tracking Network.	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2025-10-17T21:27:50-04:00